Global Cell and Gene Therapy Manufacturing Quality Control Market Growth (Status and Outlook) 2026-2032
The global Cell and Gene Therapy Manufacturing Quality Control market size is predicted to grow from US$ 639 million in 2025 to US$ 2200 million in 2032; it is expected to grow at a CAGR of 19.7% from 2026 to 2032.
United States market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell and Gene Therapy Manufacturing Quality Control players cover Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Manufacturing Quality Control Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Manufacturing Quality Control sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Manufacturing Quality Control sales for 2026 through 2032. With Cell and Gene Therapy Manufacturing Quality Control sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Manufacturing Quality Control industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Manufacturing Quality Control landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy Manufacturing Quality Control portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Manufacturing Quality Control market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Manufacturing Quality Control and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Manufacturing Quality Control.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Manufacturing Quality Control market by product type, application, key players and key regions and countries.
Segmentation by Type:
United States market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Cell and Gene Therapy Manufacturing Quality Control is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Cell and Gene Therapy Manufacturing Quality Control players cover Bio-Rad Laboratories,Inc., QIAGEN, Charles River Laboratories International, Inc., Lonza Group AG, Bio-Techne Corporation, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LPI (LP Information)' newest research report, the “Cell and Gene Therapy Manufacturing Quality Control Industry Forecast” looks at past sales and reviews total world Cell and Gene Therapy Manufacturing Quality Control sales in 2025, providing a comprehensive analysis by region and market sector of projected Cell and Gene Therapy Manufacturing Quality Control sales for 2026 through 2032. With Cell and Gene Therapy Manufacturing Quality Control sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell and Gene Therapy Manufacturing Quality Control industry.
This Insight Report provides a comprehensive analysis of the global Cell and Gene Therapy Manufacturing Quality Control landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Cell and Gene Therapy Manufacturing Quality Control portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell and Gene Therapy Manufacturing Quality Control market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell and Gene Therapy Manufacturing Quality Control and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell and Gene Therapy Manufacturing Quality Control.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell and Gene Therapy Manufacturing Quality Control market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Sterility Testing
- Purity Testing
- Potency Testing
- Identity Testing
- Others
- Pharmaceutical & Biotechnology Companies
- Contract Manufacturing Organizations
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bio-Rad Laboratories,Inc.
- QIAGEN
- Charles River Laboratories International, Inc.
- Lonza Group AG
- Bio-Techne Corporation
- Merck KGaA
- F. Hoffmann-La Roche Ltd
- Thermo Fisher Scientific, Inc.
- Intertek Group Plc
- Eurofins Scientific S.E.
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size (2021-2032)
2.1.2 Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy Manufacturing Quality Control by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy Manufacturing Quality Control Segment by Type
2.2.1 Sterility Testing
2.2.2 Purity Testing
2.2.3 Potency Testing
2.2.4 Identity Testing
2.2.5 Others
2.2.6 Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
2.2.6.1 Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy Manufacturing Quality Control Segment by Application
2.3.1 Pharmaceutical & Biotechnology Companies
2.3.2 Contract Manufacturing Organizations
2.3.3 Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
2.3.3.1 Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL BY REGION
4.1 Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL MARKET FORECAST
10.1 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy Manufacturing Quality Control Forecast
10.1.3 APAC Cell and Gene Therapy Manufacturing Quality Control Forecast
10.1.4 Europe Cell and Gene Therapy Manufacturing Quality Control Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2 Americas Cell and Gene Therapy Manufacturing Quality Control Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2.2 Canada Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2.3 Mexico Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2.4 Brazil Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3 APAC Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy Manufacturing Quality Control Market Forecast
10.3.2 Japan Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.3 Korea Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.5 India Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.6 Australia Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4 Europe Cell and Gene Therapy Manufacturing Quality Control Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.2 France Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.3 UK Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.4 Italy Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.5 Russia Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5.2 South Africa Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5.3 Israel Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5.4 Turkey Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.6 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy Manufacturing Quality Control Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bio-Rad Laboratories,Inc.
11.1.1 Bio-Rad Laboratories,Inc. Company Information
11.1.2 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bio-Rad Laboratories,Inc. Main Business Overview
11.1.5 Bio-Rad Laboratories,Inc. Latest Developments
11.2 QIAGEN
11.2.1 QIAGEN Company Information
11.2.2 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 QIAGEN Main Business Overview
11.2.5 QIAGEN Latest Developments
11.3 Charles River Laboratories International, Inc.
11.3.1 Charles River Laboratories International, Inc. Company Information
11.3.2 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Charles River Laboratories International, Inc. Main Business Overview
11.3.5 Charles River Laboratories International, Inc. Latest Developments
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Information
11.4.2 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lonza Group AG Main Business Overview
11.4.5 Lonza Group AG Latest Developments
11.5 Bio-Techne Corporation
11.5.1 Bio-Techne Corporation Company Information
11.5.2 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bio-Techne Corporation Main Business Overview
11.5.5 Bio-Techne Corporation Latest Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Merck KGaA Main Business Overview
11.6.5 Merck KGaA Latest Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Information
11.7.2 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.7.5 F. Hoffmann-La Roche Ltd Latest Developments
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Information
11.8.2 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific, Inc. Latest Developments
11.9 Intertek Group Plc
11.9.1 Intertek Group Plc Company Information
11.9.2 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Intertek Group Plc Main Business Overview
11.9.5 Intertek Group Plc Latest Developments
11.10 Eurofins Scientific S.E.
11.10.1 Eurofins Scientific S.E. Company Information
11.10.2 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eurofins Scientific S.E. Main Business Overview
11.10.5 Eurofins Scientific S.E. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Market Size (2021-2032)
2.1.2 Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Cell and Gene Therapy Manufacturing Quality Control by Country/Region (2021, 2025 & 2032)
2.2 Cell and Gene Therapy Manufacturing Quality Control Segment by Type
2.2.1 Sterility Testing
2.2.2 Purity Testing
2.2.3 Potency Testing
2.2.4 Identity Testing
2.2.5 Others
2.2.6 Cell and Gene Therapy Manufacturing Quality Control Market Size by Type
2.2.6.1 Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
2.3 Cell and Gene Therapy Manufacturing Quality Control Segment by Application
2.3.1 Pharmaceutical & Biotechnology Companies
2.3.2 Contract Manufacturing Organizations
2.3.3 Cell and Gene Therapy Manufacturing Quality Control Market Size by Application
2.3.3.1 Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.3.2 Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
3 CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL MARKET SIZE BY PLAYER
3.1 Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Player
3.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2021-2026)
3.1.2 Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Player (2021-2026)
3.2 Global Cell and Gene Therapy Manufacturing Quality Control Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL BY REGION
4.1 Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026)
4.2 Global Cell and Gene Therapy Manufacturing Quality Control Annual Revenue by Country/Region (2021-2026)
4.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
4.4 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
4.5 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
4.6 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026)
5.2 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
5.3 Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026)
6.2 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
6.3 APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026)
7.2 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
7.3 Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control by Region (2021-2026)
8.2 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026)
8.3 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL AND GENE THERAPY MANUFACTURING QUALITY CONTROL MARKET FORECAST
10.1 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.1.1 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.1.2 Americas Cell and Gene Therapy Manufacturing Quality Control Forecast
10.1.3 APAC Cell and Gene Therapy Manufacturing Quality Control Forecast
10.1.4 Europe Cell and Gene Therapy Manufacturing Quality Control Forecast
10.1.5 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2 Americas Cell and Gene Therapy Manufacturing Quality Control Forecast by Country (2027-2032)
10.2.1 United States Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2.2 Canada Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2.3 Mexico Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.2.4 Brazil Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3 APAC Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.3.1 China Cell and Gene Therapy Manufacturing Quality Control Market Forecast
10.3.2 Japan Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.3 Korea Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.4 Southeast Asia Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.5 India Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.3.6 Australia Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4 Europe Cell and Gene Therapy Manufacturing Quality Control Forecast by Country (2027-2032)
10.4.1 Germany Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.2 France Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.3 UK Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.4 Italy Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.4.5 Russia Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5 Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Forecast by Region (2027-2032)
10.5.1 Egypt Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5.2 South Africa Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5.3 Israel Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.5.4 Turkey Market Cell and Gene Therapy Manufacturing Quality Control Forecast
10.6 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Type (2027-2032)
10.7 Global Cell and Gene Therapy Manufacturing Quality Control Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Cell and Gene Therapy Manufacturing Quality Control Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bio-Rad Laboratories,Inc.
11.1.1 Bio-Rad Laboratories,Inc. Company Information
11.1.2 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.1.3 Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 Bio-Rad Laboratories,Inc. Main Business Overview
11.1.5 Bio-Rad Laboratories,Inc. Latest Developments
11.2 QIAGEN
11.2.1 QIAGEN Company Information
11.2.2 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.2.3 QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 QIAGEN Main Business Overview
11.2.5 QIAGEN Latest Developments
11.3 Charles River Laboratories International, Inc.
11.3.1 Charles River Laboratories International, Inc. Company Information
11.3.2 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.3.3 Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Charles River Laboratories International, Inc. Main Business Overview
11.3.5 Charles River Laboratories International, Inc. Latest Developments
11.4 Lonza Group AG
11.4.1 Lonza Group AG Company Information
11.4.2 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.4.3 Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Lonza Group AG Main Business Overview
11.4.5 Lonza Group AG Latest Developments
11.5 Bio-Techne Corporation
11.5.1 Bio-Techne Corporation Company Information
11.5.2 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.5.3 Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Bio-Techne Corporation Main Business Overview
11.5.5 Bio-Techne Corporation Latest Developments
11.6 Merck KGaA
11.6.1 Merck KGaA Company Information
11.6.2 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.6.3 Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Merck KGaA Main Business Overview
11.6.5 Merck KGaA Latest Developments
11.7 F. Hoffmann-La Roche Ltd
11.7.1 F. Hoffmann-La Roche Ltd Company Information
11.7.2 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.7.3 F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 F. Hoffmann-La Roche Ltd Main Business Overview
11.7.5 F. Hoffmann-La Roche Ltd Latest Developments
11.8 Thermo Fisher Scientific, Inc.
11.8.1 Thermo Fisher Scientific, Inc. Company Information
11.8.2 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.8.3 Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 Thermo Fisher Scientific, Inc. Main Business Overview
11.8.5 Thermo Fisher Scientific, Inc. Latest Developments
11.9 Intertek Group Plc
11.9.1 Intertek Group Plc Company Information
11.9.2 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.9.3 Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Intertek Group Plc Main Business Overview
11.9.5 Intertek Group Plc Latest Developments
11.10 Eurofins Scientific S.E.
11.10.1 Eurofins Scientific S.E. Company Information
11.10.2 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Offered
11.10.3 Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Eurofins Scientific S.E. Main Business Overview
11.10.5 Eurofins Scientific S.E. Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy Manufacturing Quality Control Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sterility Testing
Table 4. Major Players of Purity Testing
Table 5. Major Players of Potency Testing
Table 6. Major Players of Identity Testing
Table 7. Major Players of Others
Table 8. Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Table 11. Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Table 14. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Player (2021-2026)
Table 16. Cell and Gene Therapy Manufacturing Quality Control Key Players Head office and Products Offered
Table 17. Cell and Gene Therapy Manufacturing Quality Control Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Table 22. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Country (2021-2026)
Table 26. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Table 28. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Table 30. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Table 32. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Country (2021-2026)
Table 36. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Manufacturing Quality Control
Table 42. Key Market Challenges & Risks of Cell and Gene Therapy Manufacturing Quality Control
Table 43. Key Industry Trends of Cell and Gene Therapy Manufacturing Quality Control
Table 44. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Bio-Rad Laboratories,Inc. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 49. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 50. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Bio-Rad Laboratories,Inc. Main Business
Table 52. Bio-Rad Laboratories,Inc. Latest Developments
Table 53. QIAGEN Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 54. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 55. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. QIAGEN Main Business
Table 57. QIAGEN Latest Developments
Table 58. Charles River Laboratories International, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 59. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 60. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Charles River Laboratories International, Inc. Main Business
Table 62. Charles River Laboratories International, Inc. Latest Developments
Table 63. Lonza Group AG Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 64. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 65. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Lonza Group AG Main Business
Table 67. Lonza Group AG Latest Developments
Table 68. Bio-Techne Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 69. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 70. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Bio-Techne Corporation Main Business
Table 72. Bio-Techne Corporation Latest Developments
Table 73. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 74. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 75. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Merck KGaA Main Business
Table 77. Merck KGaA Latest Developments
Table 78. F. Hoffmann-La Roche Ltd Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 79. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 80. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. F. Hoffmann-La Roche Ltd Main Business
Table 82. F. Hoffmann-La Roche Ltd Latest Developments
Table 83. Thermo Fisher Scientific, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 84. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 85. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Thermo Fisher Scientific, Inc. Main Business
Table 87. Thermo Fisher Scientific, Inc. Latest Developments
Table 88. Intertek Group Plc Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 89. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 90. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Intertek Group Plc Main Business
Table 92. Intertek Group Plc Latest Developments
Table 93. Eurofins Scientific S.E. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 94. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 95. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Eurofins Scientific S.E. Main Business
Table 97. Eurofins Scientific S.E. Latest Developments
Table 1. Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Cell and Gene Therapy Manufacturing Quality Control Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Sterility Testing
Table 4. Major Players of Purity Testing
Table 5. Major Players of Potency Testing
Table 6. Major Players of Identity Testing
Table 7. Major Players of Others
Table 8. Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Table 11. Cell and Gene Therapy Manufacturing Quality Control Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Table 14. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Player (2021-2026)
Table 16. Cell and Gene Therapy Manufacturing Quality Control Key Players Head office and Products Offered
Table 17. Cell and Gene Therapy Manufacturing Quality Control Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Table 22. Global Cell and Gene Therapy Manufacturing Quality Control Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Country (2021-2026)
Table 26. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Table 28. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Table 30. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Table 32. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Country (2021-2026)
Table 36. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Cell and Gene Therapy Manufacturing Quality Control
Table 42. Key Market Challenges & Risks of Cell and Gene Therapy Manufacturing Quality Control
Table 43. Key Industry Trends of Cell and Gene Therapy Manufacturing Quality Control
Table 44. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. Bio-Rad Laboratories,Inc. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 49. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 50. Bio-Rad Laboratories,Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. Bio-Rad Laboratories,Inc. Main Business
Table 52. Bio-Rad Laboratories,Inc. Latest Developments
Table 53. QIAGEN Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 54. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 55. QIAGEN Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. QIAGEN Main Business
Table 57. QIAGEN Latest Developments
Table 58. Charles River Laboratories International, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 59. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 60. Charles River Laboratories International, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Charles River Laboratories International, Inc. Main Business
Table 62. Charles River Laboratories International, Inc. Latest Developments
Table 63. Lonza Group AG Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 64. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 65. Lonza Group AG Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Lonza Group AG Main Business
Table 67. Lonza Group AG Latest Developments
Table 68. Bio-Techne Corporation Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 69. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 70. Bio-Techne Corporation Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Bio-Techne Corporation Main Business
Table 72. Bio-Techne Corporation Latest Developments
Table 73. Merck KGaA Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 74. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 75. Merck KGaA Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Merck KGaA Main Business
Table 77. Merck KGaA Latest Developments
Table 78. F. Hoffmann-La Roche Ltd Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 79. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 80. F. Hoffmann-La Roche Ltd Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. F. Hoffmann-La Roche Ltd Main Business
Table 82. F. Hoffmann-La Roche Ltd Latest Developments
Table 83. Thermo Fisher Scientific, Inc. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 84. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 85. Thermo Fisher Scientific, Inc. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. Thermo Fisher Scientific, Inc. Main Business
Table 87. Thermo Fisher Scientific, Inc. Latest Developments
Table 88. Intertek Group Plc Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 89. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 90. Intertek Group Plc Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Intertek Group Plc Main Business
Table 92. Intertek Group Plc Latest Developments
Table 93. Eurofins Scientific S.E. Details, Company Type, Cell and Gene Therapy Manufacturing Quality Control Area Served and Its Competitors
Table 94. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Product Offered
Table 95. Eurofins Scientific S.E. Cell and Gene Therapy Manufacturing Quality Control Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Eurofins Scientific S.E. Main Business
Table 97. Eurofins Scientific S.E. Latest Developments
LIST OF FIGURES
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy Manufacturing Quality Control Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type in 2025
Figure 10. Cell and Gene Therapy Manufacturing Quality Control in Pharmaceutical & Biotechnology Companies
Figure 11. Global Cell and Gene Therapy Manufacturing Quality Control Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 12. Cell and Gene Therapy Manufacturing Quality Control in Contract Manufacturing Organizations
Figure 13. Global Cell and Gene Therapy Manufacturing Quality Control Market: Contract Manufacturing Organizations (2021-2026) & ($ millions)
Figure 14. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application in 2025
Figure 15. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Player in 2025
Figure 16. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 18. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 19. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 21. Americas Cell and Gene Therapy Manufacturing Quality Control Value Market Share by Country in 2025
Figure 22. United States Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region in 2025
Figure 27. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Figure 29. China Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Country in 2025
Figure 36. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 52. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 53. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 55. United States Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 56. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 59. China Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 60. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 61. Korea Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 63. India Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 64. Australia Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 65. Germany Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 66. France Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 67. UK Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 68. Italy Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 69. Russia Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 72. Israel Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 74. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 1. Cell and Gene Therapy Manufacturing Quality Control Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Cell and Gene Therapy Manufacturing Quality Control Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country/Region (2025)
Figure 8. Cell and Gene Therapy Manufacturing Quality Control Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type in 2025
Figure 10. Cell and Gene Therapy Manufacturing Quality Control in Pharmaceutical & Biotechnology Companies
Figure 11. Global Cell and Gene Therapy Manufacturing Quality Control Market: Pharmaceutical & Biotechnology Companies (2021-2026) & ($ millions)
Figure 12. Cell and Gene Therapy Manufacturing Quality Control in Contract Manufacturing Organizations
Figure 13. Global Cell and Gene Therapy Manufacturing Quality Control Market: Contract Manufacturing Organizations (2021-2026) & ($ millions)
Figure 14. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application in 2025
Figure 15. Global Cell and Gene Therapy Manufacturing Quality Control Revenue Market Share by Player in 2025
Figure 16. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Figure 17. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 18. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 19. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 20. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size 2021-2026 ($ millions)
Figure 21. Americas Cell and Gene Therapy Manufacturing Quality Control Value Market Share by Country in 2025
Figure 22. United States Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 23. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 24. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 25. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 26. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region in 2025
Figure 27. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Figure 28. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Figure 29. China Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 30. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 31. South Korea Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 32. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 33. India Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 34. Australia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 35. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Country in 2025
Figure 36. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Figure 37. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Figure 38. Germany Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 39. France Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 40. UK Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 41. Italy Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 42. Russia Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 43. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Region (2021-2026)
Figure 44. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Type (2021-2026)
Figure 45. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share by Application (2021-2026)
Figure 46. Egypt Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 47. South Africa Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 48. Israel Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 49. Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 50. GCC Countries Cell and Gene Therapy Manufacturing Quality Control Market Size Growth 2021-2026 ($ millions)
Figure 51. Americas Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 52. APAC Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 53. Europe Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 54. Middle East & Africa Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 55. United States Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 56. Canada Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 57. Mexico Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 58. Brazil Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 59. China Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 60. Japan Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 61. Korea Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 62. Southeast Asia Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 63. India Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 64. Australia Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 65. Germany Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 66. France Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 67. UK Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 68. Italy Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 69. Russia Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 70. Egypt Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 71. South Africa Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 72. Israel Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 73. Turkey Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
Figure 74. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share Forecast by Type (2027-2032)
Figure 75. Global Cell and Gene Therapy Manufacturing Quality Control Market Size Market Share Forecast by Application (2027-2032)
Figure 76. GCC Countries Cell and Gene Therapy Manufacturing Quality Control Market Size 2027-2032 ($ millions)
